Upload

Loading icon Loading...

This video is unavailable.

FDA Reauthorization Bill is "Must Pass" Legislation

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to like HELPCommitteeGOP's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to dislike HELPCommitteeGOP's video.

Sign in to YouTube

Sign in with your Google Account (YouTube, Google+, Gmail, Orkut, Picasa, or Chrome) to add HELPCommitteeGOP's video to your playlist.

Published on May 21, 2012

WASHINGTON, D.C. -- During remarks made today in support of the Food and Drug Administration (FDA) User Fee Reauthorization Bill (S. 3187), Senator Mike Enzi (R-Wyo.), Ranking Member on the Senate Health, Education, Labor and Pensions (HELP) Committee, said this legislation represents a strong bipartisan approach in making important changes to how FDA does business and is "must pass" legislation.

Loading icon Loading...

Loading icon Loading...

Loading icon Loading...

The interactive transcript could not be loaded.

Loading icon Loading...

Loading icon Loading...

Ratings have been disabled for this video.
Rating is available when the video has been rented.
This feature is not available right now. Please try again later.

Loading icon Loading...

Loading...
Working...
Sign in to add this to Watch Later

Add to